Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Caprelsa 300 mg film coated tablets

Active Ingredient:
vandetanib
Company:  
SANOFI See contact details
ATC code: 
L01EX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Caprelsa - Healthcare Professional (HCP) Guide - Risk Minimisation Information for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

{pdf_link}

Caprelsa - Patient Alert Card

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

{pdf_link}

Caprelsa - Patient Guide - Risk Minimisation Information for Patients

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

SANOFI
Company image
Address
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0)800 035 2525
Telephone
+44 (0)118 354 3000